Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?
Primary Purpose
Infertility
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Embryo transfer
Sponsored by
About this trial
This is an interventional treatment trial for Infertility
Eligibility Criteria
Inclusion Criteria:
- women undergoing primary IVF/ICSI cycles for tubal factor/unexplained infertility and had blastocyst-stage ET
Exclusion Criteria:
- cleavage-stage ET.
- women who had no good-quality embryos to transfer
- women who had known poor endometrial receptivity
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Good-quality embryo transfer
good- and poor-quality embryo transfer
Arm Description
Women who had only good-quality embryo transfer
Women who had both good- and poor-quality embryo transfer
Outcomes
Primary Outcome Measures
Ongoing clinical pregnancy rate
viable intrauterine pregnancy ongoing beyond 12 weeks of gestation
Secondary Outcome Measures
Biochemical pregnancy rate
positive serum hCG
Clinical pregnancy rate
sonographic detection of viable intrauterine gestational sac
Multiple pregnancy rate
No. of intrauterine gestational sacs
Ectopic pregnancy rate
Extrauterine pregnancy
Full Information
NCT ID
NCT03113097
First Posted
April 10, 2017
Last Updated
April 10, 2017
Sponsor
Ain Shams University
Collaborators
Dar El Teb Institute
1. Study Identification
Unique Protocol Identification Number
NCT03113097
Brief Title
Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?
Official Title
Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
June 2014 (Actual)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
March 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ain Shams University
Collaborators
Dar El Teb Institute
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Women planned to undergo blastocyst-stage embryo transfer after IVF/ICSI were randomized into 2 groups:
group I: women who had only good-quality embryo transfer.
group II: women who had both good-quality and poor-quality embryo transfer.
primary outcome was ongoing clinical pregnancy rate
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
627 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Good-quality embryo transfer
Arm Type
Active Comparator
Arm Description
Women who had only good-quality embryo transfer
Arm Title
good- and poor-quality embryo transfer
Arm Type
Active Comparator
Arm Description
Women who had both good- and poor-quality embryo transfer
Intervention Type
Other
Intervention Name(s)
Embryo transfer
Intervention Description
Transfer of different qualities of embryos at blastocyst stage
Primary Outcome Measure Information:
Title
Ongoing clinical pregnancy rate
Description
viable intrauterine pregnancy ongoing beyond 12 weeks of gestation
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Biochemical pregnancy rate
Description
positive serum hCG
Time Frame
2 weeks after ET
Title
Clinical pregnancy rate
Description
sonographic detection of viable intrauterine gestational sac
Time Frame
4 weeks after ET
Title
Multiple pregnancy rate
Description
No. of intrauterine gestational sacs
Time Frame
4-6 weeks after ET
Title
Ectopic pregnancy rate
Description
Extrauterine pregnancy
Time Frame
6 weeks after ET
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
women undergoing primary IVF/ICSI cycles for tubal factor/unexplained infertility and had blastocyst-stage ET
Exclusion Criteria:
cleavage-stage ET.
women who had no good-quality embryos to transfer
women who had known poor endometrial receptivity
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mohammed Faris, MD
Organizational Affiliation
Dar El Teb IVF and Infertility Center
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?
We'll reach out to this number within 24 hrs